Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
Abstract Background Sleep is essential for wellbeing, yet sleep disturbance is a common problem linked to a wide range of health conditions. Palmitoylethanolamide (PEA) is an endogenous fatty acid amide proposed to promote better sleep via potential interaction with the endocannabinoid system. Metho...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Sleep Science and Practice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41606-021-00065-3 |